Advertisement

Breast Cancer

, Volume 7, Issue 3, pp 221–230 | Cite as

Cytokines facilitate chemotactic motility of breast carcinoma cells

  • Koji Arihiro
  • Hiroyo Oda
  • Mayumi Kaneko
  • Kouki Inai
Original Article

Abstract

Background

Both growth and motility of various tumor cells have been shown to be influenced by surrounding cells such as lymphocytes, histiocytes and fibroblasts through various cytokines, growth factors and extracellular matrices. The role of cytokines and extracellular matrices produced by lymphocytes, histiocytes and fibroblasts on migration and invasion of breast carcinoma cells has not been fully investigated.

Methods

We investigated the effect of hepatocyte growth factor (HGF), interleukin (IL)-6, IL-8, IL-11, soluble type IV collagen and soluble laminin on the migration of 3 human breast carcinoma cell lines, MDA-MB-231, MCF-7 and T-47D, using a cell culture insert and a biocoat matrigel invasion chamber to assess migration across a matrigel-coated polyethylene telephtalate membrane.

Results

HGF, IL-6, IL-11 and IL-8 induced significant migration of MDA-MB-231 cells depending on the dose of each cytokine. However, type IV collagen and laminin inhibited migration of MDA-MB-231 cells. In contrast, IL-8 inhibited migration of MCF-7 cells and IL-6 induced significant migration of T-47D cells, while no other cytokine or extracellular matrix induced significant migration of MCF-7 and T-47D cells. Only HGF induced significant invasion of MDA-MB-231 cells depending on the dose. MCF-7 and T-47D cells did not invade in response to any of the cytokines and extracellular matrices tested.

Conclusions

These results suggest the possibility that the potency of chemotaxis or chemoinvasion differs according to the breast carcinoma cell line and that various cytokines and extracellular matrices secreted by lymphocytes, histiocytes and fibroblasts in the stroma of breast carcinoma can affect the invasion of breast carcinoma cells.

Key words

Breast carcinoma cells Motility HGF IL-6 IL-11 

Abbreviations

HGF

Hepatocyte growth factor

IL

Interleukin

ER

Estrogen receptor

IGFRs

Insulin-like growth factor receptors

EGFR

Epidermal growth factor receptor

TGF-βR

Transforming growth factor-beta receptor

TNFR

Tumor necrosis factor receptor

EGF

Epidermal growth factor

TGF

Transforming growth factor

bFGF

Basic fibroblast growth factor

PDGF

Platelet-derived growth factor

RANTES

Regulated on activation, normal T-cells, expressed and secreted

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1).
    Sakakura T, Kusano I: Tenascin in tissue perturbation repair.Acta Pathol Jpn 41:247–258, 1991.PubMedGoogle Scholar
  2. 2).
    Ishihara A, Yoshida T, Tamaki H,et al: Tenascin expression in cancer cells and stroma of human breast cancer and its prognostic significance.Clin Cancer Res 1:1035–1041, 1995.PubMedGoogle Scholar
  3. 3).
    van Roozendaal CEP, van Ooijen B, Klijn JGM: Stroma influences on breast cancer cell growth.Br J Cancer 65:77–81, 1992.PubMedGoogle Scholar
  4. 4).
    Adam L, Crepin M, Lelong J-P,et al: Selective interactions between mammary epithelial cells and fibroblasts in co-culture.Int J Cancer 59:262–268, 1994.PubMedCrossRefGoogle Scholar
  5. 5).
    Bani D, Riva A, Bigazzi M,et al: Differentiation of breast cancer cellsin vitro is promoted by the concurrent influence of myoepithelial cells and relaxin.Br J Cancer 70:900–904, 1994.PubMedGoogle Scholar
  6. 6).
    Ito A, Nakajima S, Sasaguri Y,et al: Co-culture of human breast adenocarcinoma MCF-7 cells and human dermal fibroblasts enhances the production of matrix metalloproteinases 1, 2 and 3 in fibroblasts.Br J Cancer 71:1039–1045, 1995.PubMedGoogle Scholar
  7. 7).
    Matsumoto K, Nakamura T: Emerging multipotent aspects of hepatocyte growth factor.J Biochem 119:591–600, 1996.PubMedGoogle Scholar
  8. 8).
    Tuck AB, Park M, Sterns EE,et al: Coexpression of hepatocyte growth factor and receptor (met) in human breast carcinoma.Am J Pathol 148:225–232, 1996.PubMedGoogle Scholar
  9. 9).
    Yamashita J, Ogawa M, Yamashita S,et al: Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer.Cancer Res 54:1630–1633, 1994.PubMedGoogle Scholar
  10. 10).
    Yao Y, Jin L, Fuchs A,et al: Scatter factor protein levels in human breast cancers.Am J Pathol 149:1707–1717, 1996.PubMedGoogle Scholar
  11. 11).
    Taniguchi T, Toi M, Inada K,et al: Serum concentrations of hepatocyte growth factor in breast cancer patients.Clin Cancer Res 1:1031–1034, 1995.PubMedGoogle Scholar
  12. 12).
    Toi M, Taniguchi T, Ueno T,et al: Significance of circulating hepatocyte growth factor as a prognostic indicator in primary breast cancer.Clin Cancer Res 4:659–664, 1998.PubMedGoogle Scholar
  13. 13).
    Jin L, Fuchs A, Schnitt SJ,et al: Expression of scatter factor and c-met receptor in benign and malignant breast tissue.Cancer 79:749–760, 1997.PubMedCrossRefGoogle Scholar
  14. 14).
    Van Snick J: Interleukin-6: an overview.Annu Rev Immunol 8:253–278, 1990.PubMedCrossRefGoogle Scholar
  15. 15).
    Zhang GJ, Adachi I: Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma.Anticancer Res 19:1527–1432, 1999.Google Scholar
  16. 16).
    Fontanini G, Campani D, Roncella M,et al. Expression of interleukin 6 (IL-6) correlates with oestrogen receptor in human breast carcinoma.Br J Cancer 80:579–584, 1999.PubMedCrossRefGoogle Scholar
  17. 17).
    Fourcin M, Chevalier S, Lebrun JJ,et al: Involvement of gpl30/ interleukin-6 receptor transducing component in interleukin-11 receptor,Eur J Immunol 24:277–280, 1994.PubMedCrossRefGoogle Scholar
  18. 18).
    Mukaida N, Harada A, Yasumoto K,et al: Properties of pro-inflammatory cell type-specific leukocyte chemotactic cytokines, interleukin 8 (IL-8) and monocyte chemotactic and activating factor.Microbiol Immunol 36:773–789, 1992.PubMedGoogle Scholar
  19. 19).
    Arihiro K, Inai K, Kurihara K,et al: Distribution of laminin, type IV collagen and fibronectin in the invasive component of breast carcinoma.Acta Pathol Jpn 43:758–764, 1993.PubMedGoogle Scholar
  20. 20).
    Saiki I, Murata J, Yoneda J,et al: Influence of fibroblasts on the invasion and migration of highly or weakly metastatic B16 melanoma cells.Int J Cancer 56:867–873, 1994.PubMedCrossRefGoogle Scholar
  21. 21).
    Cailleau R, Young R, Olive M,et al: Breast tumor cell lines from pleural effusions.J Natl Cancer Inst 53:661–674, 1974.PubMedGoogle Scholar
  22. 22).
    Crepin M, Salle V, Raux H,et al: Steroid hormone receptors and tumorigenicity of sublines from breast tumor metastatic MDA-MB 231 cell line.Anticancer Res 10:1661–1666, 1990.PubMedGoogle Scholar
  23. 23).
    De Leon DD, Bakker B, Wilson DM,et al: Demonstration of insulin-like growth factor (IGF-I and-II) receptors and binding protein in human breast cancer cell lines.Biochem Biophys Res Commun 152:398–405, 1988.PubMedCrossRefGoogle Scholar
  24. 24).
    Martinez-Carpio PA, Mur C, Rosel P,et al: Constitutive and regulated secretion of epidermal growth factor and transforming growth factor-betal in MDA- MB-231 breast cancer cell line in 11-day cultures.Cell Signal 11:753–757, 1999.PubMedCrossRefGoogle Scholar
  25. 25).
    Brooks SC, Locke ER, Soule HD: Estrogen receptor in a human cell line (MCF-7) from breast carcinoma.J Biol Chem 248:6251–6253, 1973.PubMedGoogle Scholar
  26. 26).
    Perroteau I, Salomon D, DeBortoli M,et al: Immunological detection and quantitation of alpha transforming growth factors in human breast carcinoma cells.Breast Cancer Res Treat 7:201–210, 1986.PubMedCrossRefGoogle Scholar
  27. 27).
    Creasey AA, Yamamoto R, Vitt CR: A high molecular weight component of the human tumor necrosis factor receptor is associated with cytotoxicity.Proc Natl Acad Sci USA 84:3293–3297, 1987.PubMedCrossRefGoogle Scholar
  28. 28).
    Lafon C, Mazars P, Guerrin M,et al: Early gene responses associated with transforming growth factorbeta 1 growth inhibition and autoinduction in MCF-7 breast adenocarcinoma cells.Biochim Biophys Acta 1266:288–295, 1995.PubMedCrossRefGoogle Scholar
  29. 29).
    Keydar I, Chen L, Karby S,et al: Establishment and characterization of a cell line of human breast carci- noma origin.Eur J Cancer 15:659–663, 1979.PubMedGoogle Scholar
  30. 30).
    Reddel RR, Murphy LC, Sutherland RL: Factors affecting the sensitivity of T-47D human breast cancer cells to tamoxifen.Cancer Res 44:2398–2405, 1984.PubMedGoogle Scholar
  31. 31).
    Sawyer C, Hiles I, Page M,et al: Two erbB-4 transcripts are expressed in normal breast and in most breast cancers.Oncogene 17:919–924, 1998.PubMedCrossRefGoogle Scholar
  32. 32).
    Weidner KM, Behrens J, Vandekerckhove J,et al: Scatter factor. Molecular characteristics and effect on the invasiveness of epithelial cells.J Cell Biol 111:2097–2108, 1990.PubMedCrossRefGoogle Scholar
  33. 33).
    Tajima H, Matsumoto K, Nakamura T,et al: Regulation of cell growth and motility by hepatocyte growth factor and receptor expression in various cell species.Exp Cell Res 202:423–431, 1992.PubMedCrossRefGoogle Scholar
  34. 34).
    Matsumoto K, Date K, Shimura H,et al: Acquisition of invasive phenotype in gallbladder cancer cells via mutual interaction of stromal fibroblasts and cancer cells as mediated by hepatocyte growth factor.Jpn J Cancer Res 87:702–710, 1996.PubMedGoogle Scholar
  35. 35).
    Yi S, Chen JR, Viallet J,et al: Paracrine effects of hepatocyte growth factor/scatter factor on non-small- cell lung carcinoma cell lines.Br J Cancer 77:2162–2170, 1998.PubMedGoogle Scholar
  36. 36).
    Beviglia L, Matsumoto K, Lin CS,et al: Expression of the c-Met/HGF receptor in human breast carcinoma. Correlation with tumor progression.Int J Cancer 74:301–309, 1997.PubMedCrossRefGoogle Scholar
  37. 37).
    Beviglia L, Kramer RH: HGF induces FAK activation and integrin-mediated adhesion in MTLn3 breast carcinoma cell.Int J Cancer 83:640–649, 1999.PubMedCrossRefGoogle Scholar
  38. 38).
    Tamm I, Cardinale I, Krueger J,et al: Interleukin 6 decreases cell-cell association and increases motility of ductal breast carcinoma cells.J Exp Med 170:1649–1669, 1989.PubMedCrossRefGoogle Scholar
  39. 39).
    Tamm I, Cardinale I, Murphy J: Decreased adherence of interleukin 6-treated breast carcinoma cells can lead to separation from neighbors after mitosis.Proc Natl Acad Set USA 88:4414–4418, 1991.CrossRefGoogle Scholar
  40. 40).
    Tamm I, Cardinale I, Kikuchi T,et al: E-cadherin distribution in interleukin 6-induced cell-cell separation of ductal breast carcinoma cells.Proc Natl Acad Sci USA 91:4338–4342, 1994.PubMedCrossRefGoogle Scholar
  41. 41).
    Tamm I, Kikuchi T, Cardinale I,et al: Cell-adhesion- disrupting action of interleukin 6 in human ductal breast carcinoma cells.Proc Natl Acad Sci USA 91:3329–3333, 1994.PubMedCrossRefGoogle Scholar
  42. 42).
    Chiu JJ, Sgagias MK, Cowan KH,et al: Interleukin 6 acts as a paracrine growth factor in human mammary carcinoma cell lines.Clin Cancer Res 2:215–221, 1996.PubMedGoogle Scholar
  43. 43).
    Youngs SJ, Ali SA, Taub DD,et al: Chemokines in- duce migrational responses in human breast carci-noma cell lines.Int J Cancer 71:257–266, 1997.PubMedCrossRefGoogle Scholar
  44. 44).
    Crichton MB, Nichols JE, Zhao Y,et al: Expression of transcripts of interleukin-6 and related cytokines by human breast tumors, breast cancer cells, and adipose stromal cells.Mol Cell Endocrinol 118:215–220, 1996.PubMedCrossRefGoogle Scholar
  45. 45).
    Weidner KM, Arakaki N, Hartmann G,et al: Evidence for the identity of human scatter factor and human hepatocyte growth factor.Proc Natl Acad Sci USA 88:7001–7005, 1991.PubMedCrossRefGoogle Scholar
  46. 46).
    Seslar SP, Nakamura T, Byers SW,et al: Regulation of fibroblast hepatocyte growth factor/Scatter factor expression by human breast carcinoma cell lines and peptide growth factors.Cancer Res 53:1233–1238, 1993.PubMedGoogle Scholar
  47. 47).
    Rosen EM, Joseph A, Jin L,et al: Regulation of scatter factor production via a soluble inducing factor.J Cell Biol 127:225–234, 1994.PubMedCrossRefGoogle Scholar
  48. 48).
    Nakamura T, Matsumoto K, Kiritoshi A,et al: Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: In vitro analysis of tumor-stromal interactions.Cancer Res 57:3305–3313, 1997.PubMedGoogle Scholar
  49. 49).
    Moghul A, Lin L, Beedle A,et al: Modulation of c-met proto-oncogene (HGF receptor) mRNA abundance by cytokines and hormones: evidence for rapid decay of the 8kb c-met transcript.Oncogene 9:2045–2052, 1994.PubMedGoogle Scholar
  50. 50).
    Nakajima M, Chop AM: Tumor invasion and extracellular matrix degradative enzymes: regulation of activity by organ factors.Semin Cancer Biol 2:115–127, 1991.PubMedGoogle Scholar

Copyright information

© The Japanese Breast Cancer Society 2000

Authors and Affiliations

  • Koji Arihiro
    • 1
  • Hiroyo Oda
    • 1
  • Mayumi Kaneko
    • 1
  • Kouki Inai
    • 1
  1. 1.Second Department of PathologyHiroshima University School of MedicineJapan

Personalised recommendations